Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q4 2013 (Next →)
Filing Date: Feb 14, 2014
Total Value: $345M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MEDIVATION INC | 546,900 | $34.9M | 10.1% | $63.82 | — | COM | 58501N101 |
| — | CUBIST PHARMACEUTICALS INC | 400,000 | $27.55M | 8.0% | $68.87 | — | COM | 229678107 |
| — | KERYX BIOPHARMACEUTICALS | 1,700,000 | $22.02M | 6.4% | $12.95 | — | COM | 492515101 |
| — | DYAX CORP | 2,850,000 | $21.48M | 6.2% | $7.54 | — | COM | 26746E103 |
| PBYI | PUMA BIOTECHNOLOGY INC | 200,000 | $20.71M | 6.0% | $58.69 | 0.0% | COM | 74587V107 |
| — | CELGENE CORP | 120,000 | $20.28M | 5.9% | $168.97 | — | COM | 151020104 |
| ACAD | ACADIA PHARMACEUTICALS INC | 800,000 | $19.99M | 5.8% | $23.59 | 0.0% | COM | 004225108 |
| — | IDENIX PHARMACEUTICALS INC | 2,925,000 | $17.49M | 5.1% | $5.98 | — | COM | 45166R204 |
| GERN | GERON CORP | 3,397,156 | $16.1M | 4.7% | $4.29 | 0.0% | COM | 374163103 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 250,000 | $16.07M | 4.7% | $59.65 | 0.0% | COM | 02043Q107 |
| BMY | BRISTOL-MYERS SQUIBB CO | 270,000 | $14.35M | 4.2% | $34.16 | 0.0% | COM | 110122108 |
| — | ARROWHEAD RESEARCH CORP | 995,500 | $10.8M | 3.1% | $10.85 | — | COM NEW | 042797209 |
| DXCM | DEXCOM INC | 300,000 | $10.62M | 3.1% | $7.91 | 0.0% | COM | 252131107 |
| — | RECEPTOS INC | 350,000 | $10.15M | 2.9% | $28.99 | — | COM | 756207106 |
| — | ARRAY BIOPHARMA INC | 1,750,000 | $8.768M | 2.5% | $5.01 | — | COM | 04269X105 |
| — | ACELRX PHARMACEUTICALS INC | 750,000 | $8.483M | 2.5% | $11.31 | — | COM | 00444T100 |
| — | TESARO INC | 300,000 | $8.472M | 2.5% | $28.24 | — | COM | 881569107 |
| — | CLOVIS ONCOLOGY INC | 119,300 | $7.19M | 2.1% | $60.27 | — | COM | 189464100 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 100,000 | $7.035M | 2.0% | $67.90 | 0.0% | COM | 09061G101 |
| — | ALKERMES PLC | 150,000 | $6.099M | 1.8% | $40.66 | — | SHS | 00B56GVS1 |
| — | AMAG PHARMACEUTICALS INC | 250,000 | $6.07M | 1.8% | $24.28 | — | COM | 00163U106 |
| PODD | INSULET CORP | 150,000 | $5.565M | 1.6% | $36.94 | 0.0% | COM | 45784P101 |
| — | NOVAVAX INC | 1,000,000 | $5.12M | 1.5% | $5.12 | — | COM | 670002104 |
| PCRX | PACIRA PHARMACEUTICALS INC | 50,000 | $2.875M | 0.8% | $52.58 | 0.0% | COM | 695127100 |
| SGMO | SANGAMO BIOSCIENCES INC | 166,200 | $2.309M | 0.7% | $11.51 | 0.0% | COM | 800677106 |
| — | KARYOPHARM THERAPEUTICS INC | 100,000 | $2.292M | 0.7% | $22.92 | — | COM | 48576U106 |
| — | CHIMERIX INC | 143,000 | $2.161M | 0.6% | $15.11 | — | COM | 16934W106 |
| BCRX | BIOCRYST PHARMACEUTICALS | 268,000 | $2.037M | 0.6% | $6.33 | 0.0% | COM | 09058V103 |
| — | PORTOLA PHARMACEUTICALS INC | 75,000 | $1.931M | 0.6% | $25.75 | — | COM | 737010108 |
| — | OSIRIS THERAPEUTICS INC NEW | 107,800 | $1.733M | 0.5% | $16.08 | — | COM | 68827R108 |
| — | XENOPORT INC | 200,000 | $1.15M | 0.3% | $5.75 | — | COM | 98411C100 |
| — | REGULUS THERAPEUTICS INC | 100,000 | $739K | 0.2% | $7.39 | — | COM | 75915K101 |
| — | MOMENTA PHARMACEUTICALS INC | 27,700 | $490K | 0.1% | $17.69 | — | COM | 60877T100 |
| PTCT | PTC THERAPEUTICS INC | 28,800 | $489K | 0.1% | $17.58 | 0.0% | COM | 69366J200 |
| — | DENDREON CORP | 150,000 | $449K | 0.1% | $2.99 | — | COM | 24823Q107 |
| — | FIVE PRIME THERAPEUTICS INC | 20,000 | $336K | 0.1% | $16.80 | — | COM | 33830X104 |
| ENTA | ENANTA PHARMACEUTICALS INC | 10,000 | $273K | 0.1% | $24.23 | 0.0% | COM | 29251M106 |